These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10906343)

  • 1. On the spatial disposition of the fifth transmembrane helix and the structural integrity of the transmembrane binding site in the opioid and ORL1 G protein-coupled receptor family.
    Topham CM; Moulédous L; Meunier JC
    Protein Eng; 2000 Jul; 13(7):477-90. PubMed ID: 10906343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative molecular modeling on 3D-structure of opioid receptor-like 1 receptor.
    Huang XQ; Jiang HL; Luo XM; Chen KX; Zhu YC; Ji RY; Cao Y
    Acta Pharmacol Sin; 2000 Jun; 21(6):529-35. PubMed ID: 11360687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modelling of the ORL1 receptor and its complex with nociceptin.
    Topham CM; Moulédous L; Poda G; Maigret B; Meunier JC
    Protein Eng; 1998 Dec; 11(12):1163-79. PubMed ID: 9930666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study.
    Bera I; Laskar A; Ghoshal N
    J Mol Model; 2011 May; 17(5):1207-21. PubMed ID: 20661609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional inactivation of the nociceptin receptor by alanine substitution of glutamine 286 at the C terminus of transmembrane segment VI: evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain.
    Mouledous L; Topham CM; Moisand C; Mollereau C; Meunier JC
    Mol Pharmacol; 2000 Mar; 57(3):495-502. PubMed ID: 10692489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nociceptin (ORL1) receptor: molecular cloning and functional architecture.
    Meunier J; Mouledous L; Topham CM
    Peptides; 2000 Jul; 21(7):893-900. PubMed ID: 10998522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
    Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
    Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.
    Mollereau C; Mouledous L; Lapalu S; Cambois G; Moisand C; Butour JL; Meunier JC
    Mol Pharmacol; 1999 Feb; 55(2):324-31. PubMed ID: 9927625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors.
    Baldwin JM; Schertler GF; Unger VM
    J Mol Biol; 1997 Sep; 272(1):144-64. PubMed ID: 9299344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different domains of the ORL1 and kappa-opioid receptors are involved in recognition of nociceptin and dynorphin A.
    Lapalu S; Moisand C; Butour JL; Mollereau C; Meunier JC
    FEBS Lett; 1998 May; 427(2):296-300. PubMed ID: 9607332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.
    Filizola M; Laakkonen L; Loew GH
    Protein Eng; 1999 Nov; 12(11):927-42. PubMed ID: 10585498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3D model of the delta opioid receptor and ligand-receptor complexes.
    Alkorta I; Loew GH
    Protein Eng; 1996 Jul; 9(7):573-83. PubMed ID: 8844829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of ligand selectivity at the kappa-receptor based on the structure of the orphanin FQ receptor.
    Owens CE; Akil H
    J Pharmacol Exp Ther; 2002 Mar; 300(3):992-9. PubMed ID: 11861808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid receptor-like 1 (ORL1) molecular "road map" to understanding ligand interaction and selectivity.
    Philip AE; Poupaert JH; McCurdy CR
    Curr Top Med Chem; 2005; 5(3):325-40. PubMed ID: 15857315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative modeling and molecular dynamics studies of the delta, kappa and mu opioid receptors.
    Strahs D; Weinstein H
    Protein Eng; 1997 Sep; 10(9):1019-38. PubMed ID: 9464566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation.
    Paterlini G; Portoghese PS; Ferguson DM
    J Med Chem; 1997 Sep; 40(20):3254-62. PubMed ID: 9379445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation.
    Daga PR; Zaveri NT
    Proteins; 2012 Aug; 80(8):1948-61. PubMed ID: 22489047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modelling studies on the ORL1-receptor and ORL1-agonists.
    Bröer BM; Gurrath M; Höltje HD
    J Comput Aided Mol Des; 2003 Nov; 17(11):739-54. PubMed ID: 15072434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternatively spliced transcript of the rat nociceptin receptor ORL1 gene encodes a truncated receptor.
    Xie G; Ito E; Maruyama K; Pietruck C; Sharma M; Yu L; Pierce Palmer P
    Brain Res Mol Brain Res; 2000 Apr; 77(1):1-9. PubMed ID: 10814826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.